AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+2.35%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$14.9B
AUM Growth
+$373M
(+2.6%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
0.79%
Top 10 Holdings %
Top 10 Hldgs %
56.71%
Holding
1,166
New
198
Increased
342
Reduced
449
Closed
173
Top Buys
| 1 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
$51M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$31.3M |
| 3 |
Merck
MRK
|
$25.7M |
| 4 |
LyondellBasell Industries
LYB
|
$24.8M |
| 5 |
Johnson & Johnson
JNJ
|
$21.4M |
Top Sells
| 1 |
Broadcom
AVGO
|
$34M |
| 2 |
JPMorgan Chase
JPM
|
$32M |
| 3 |
Verizon
VZ
|
$29.4M |
| 4 |
Cameco
CCJ
|
$28.6M |
| 5 |
MPLX
MPLX
|
$24M |
Sector Composition
| 1 | Energy | 66.41% |
| 2 | Technology | 4.66% |
| 3 | Financials | 3.55% |
| 4 | Consumer Discretionary | 3.47% |
| 5 | Healthcare | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
monday.com
MNDY
$9.57B
| $1.81M | 0.01% |
+6,515
| New | +$1.81M |
|
377
Take-Two Interactive
TTWO
$44.2B
| $1.8M | 0.01% |
11,735
+182
| +2% | +$28K |
|
378
Zai Lab
ZLAB
$3.42B
| $1.8M | 0.01% |
74,665
-4,977
| -6% | -$120K |
|
|
VRNA
379
Verona Pharma
VRNA
$9.2B
| $1.8M | 0.01% |
62,578
-660
| -1% | -$19K |
|
380
SentinelOne
S
$6.25B
| $1.75M | 0.01% |
73,310
-16,712
| -19% | -$400K |
|
|
381
Alphabet (Google) Class C
GOOG
$2.84T
| $1.74M | 0.01% |
10,413
-688
| -6% | -$115K |
|
382
DoorDash
DASH
$105B
| $1.73M | 0.01% |
12,144
+726
| +6% | +$104K |
|
383
Celldex Therapeutics
CLDX
$1.52B
| $1.72M | 0.01% |
50,657
-742
| -1% | -$25.2K |
|
384
Spotify
SPOT
$146B
| $1.71M | 0.01% |
4,643
+402
| +9% | +$148K |
|
385
Ares Capital
ARCC
$15.8B
| $1.7M | 0.01% |
81,210
-4,105
| -5% | -$86K |
|
386
AngloGold Ashanti
AU
$30.2B
| $1.68M | 0.01% |
63,059
+14,851
| +31% | +$395K |
|
|
CSW
387
CSW Industrials, Inc.
CSW
$4.46B
| $1.67M | 0.01% |
4,564
+900
| +25% | +$330K |
|
388
Graco
GGG
$14.2B
| $1.64M | 0.01% |
18,724
+7,582
| +68% | +$664K |
|
389
Hudbay
HBM
$5.03B
| $1.63M | 0.01% |
177,470
+22,725
| +15% | +$209K |
|
390
Keros Therapeutics
KROS
$633M
| $1.62M | 0.01% |
27,905
-239
| -0.8% | -$13.9K |
|
391
FS KKR Capital
FSK
$5.08B
| $1.58M | 0.01% |
80,085
-2,900
| -3% | -$57.2K |
|
392
J&J Snack Foods
JJSF
$2.12B
| $1.57M | 0.01% |
9,117
-3,086
| -25% | -$531K |
|
393
GitLab
GTLB
$7.63B
| $1.57M | 0.01% |
30,407
-6,642
| -18% | -$342K |
|
394
Vericel Corp
VCEL
$1.72B
| $1.57M | 0.01% |
37,087
-818
| -2% | -$34.6K |
|
395
Intellia Therapeutics
NTLA
$1.29B
| $1.57M | 0.01% |
76,211
+974
| +1% | +$20K |
|
396
Perdoceo Education
PRDO
$2.14B
| $1.56M | 0.01% |
70,244
+14,788
| +27% | +$329K |
|
397
Neumora Therapeutics
NMRA
$272M
| $1.56M | 0.01% |
118,166
-6,252
| -5% | -$82.6K |
|
398
Agilent Technologies
A
$36.5B
| $1.54M | 0.01% |
10,352
-1,639
| -14% | -$243K |
|
399
REX American Resources
REX
$1.02B
| $1.53M | 0.01% |
33,046
-2,783
| -8% | -$129K |
|
400
Akero Therapeutics
AKRO
$3.58B
| $1.52M | 0.01% |
53,035
-904
| -2% | -$25.9K |
|